Delivery Order 47QSWA20D007S-W81K0025FA204
- This federal contract award was issued by the Defense Health Agency (DHA) to Medtox Laboratories Inc., a division of Laboratory Corporation of America Holdings. The $118,647.15 firm fixed-price delivery order is for PROFILE V ER13 PANEL DEVICE medical devices, with a period of performance through September 30, 2025. Medtox Laboratories holds a Multiple Award Schedule (MAS) contract with the General Services Administration (GSA), valued at $700,000 and active through June 2025. This MAS...
- This is a firm-fixed price delivery order awarded by the U.S. Navy's Bureau of Medicine and Surgery (BUMED) to Medtox Laboratories Inc., a division of Laboratory Corporation of America Holdings. The $16,108.00 contract is for a yearly standing order of Profile V ER 12 panel drug screening devices, with a requirement to provide 5 boxes per quarter. The contract was issued under Medtox's existing GSA Multiple Award Schedule contract for Law Enforcement and Security Services. Medtox Laboratories...
- The Department of Health and Human Services Indian Health Service awarded a $10,182.21 delivery order contract to Medtox Laboratories, Inc. for drug profile and supplies. Medtox Laboratories, Inc. will deliver the requested products and services under the Multiple Award Schedule contract vehicle. The contract has no set-aside designation and requires completion by December 5, 2022. Performance will take place in Burlington, North Carolina. Medtox Laboratories, Inc. is a division of Laboratory...
- The Indian Health Service awarded a firm fixed-price purchase order to Medtox Diagnostics, Inc. valued at $46.5K for urine drug testing kits. The contract, which carries no set-aside designation, was awarded on November 7, 2025, with performance scheduled through September 30, 2026, and will be executed in Albuquerque, New Mexico. Medtox Diagnostics, a subsidiary of Laboratory Corporation of America Holdings (LabCorp) based in Burlington, North Carolina, specializes in laboratory testing...
- This federal contract award to Medtox Diagnostics, Inc., a subsidiary of Laboratory Corporation of America Holdings, is a Blanket Purchase Agreement (BPA) to procure miscellaneous laboratory supplies for the Indian Health Service (IHS), a division of the Department of Health and Human Services. The $13,184.87 firm fixed price contract has a completion date of January 31, 2023. Medtox Diagnostics, a manufacturer of laboratory testing products and services, primarily provides drugs of abuse...
- The Indian Health Service awarded a $26,344.36 firm fixed-price purchase order to Medtox Diagnostics, Inc. for drugs of abuse testing supplies on December 28, 2020, with an ultimate completion date of September 16, 2024. The contract, which has been closed out, was performed in Crownpoint, New Mexico and was awarded without a set-aside designation. Medtox Diagnostics, a subsidiary of Laboratory Corporation of America Holdings (LabCorp), is a manufacturer of laboratory testing products and...
- The Department of Health and Human Services Indian Health Service awarded a $30,320 firm fixed price delivery order against the Multiple Award Schedule contract vehicle to Medtox Laboratories, Inc. for MEDTOX PROFILE-V ER 12 PANEL DRUG TESTS for the agency's Laboratory Department in Rosebud, South Dakota. As a division of Laboratory Corporation of America Holdings, Medtox will provide the requested drug screening panels to support clinical testing programs within the Indian Health Service...
- The Department of Health and Human Services Indian Health Service awarded a $10,123.20 delivery order contract to Medtox Laboratories, Inc. for laboratory supplies. Medtox Laboratories will deliver the supplies under its Multiple Award Schedule contract with the General Services Administration. The firm fixed price contract runs from September 8, 2023 to March 31, 2024 for supplies to be delivered to the IHS location in Lawton, Oklahoma. As the Indian Health Service provides healthcare...
- The Indian Health Service awarded a purchase order to Medtox Diagnostics, Inc. on December 30, 2020, for laboratory supplies at the Teec Nos Pos, Arizona facility serving Native American communities. This blanket purchase agreement, with a ceiling value of $8,236.72 and firm fixed-price terms, was completed by December 31, 2021, and has since been closed out with excess funds deobligated. The award was made without set-aside designation, indicating open competitive procurement. Medtox...
- Ortho-Clinical Diagnostics Inc. was awarded a $148,123.89 delivery order against its GSA Schedule contract for Critical Analyzers, Laboratory (FSS-66-III) to provide a Cost per Test Vitros 5600 Chemistry Analyzer to the Defense Health Agency (DHA). As the executive agent of the Military Health System, DHA supports medical readiness for the U.S. Armed Forces through programs like this delivery order, which will furnish DHA's medical treatment facilities with laboratory equipment from...
- Multiple Award Schedule (MAS)Master GSA Schedule
- 47QSWA20D007SFederal Supply Schedule
- 47QSWA20D007S-W81K0025FA204Delivery Order
The Defense Health Agency awarded a $151,937.25 firm fixed-price delivery order to Medtox Laboratories Inc. for urine drug testing analyzer equipment and consumables, with performance in Burlington, North Carolina and an ultimate completion date of September 30, 2030. This delivery order was issued under Medtox's General Services Administration Multiple Award Schedule contract, which serves as the primary contracting vehicle for the company's federal work. The contract was awarded through open competition with no set-aside designation. Medtox Laboratories Inc., a division of Laboratory Corporation of America Holdings and headquartered in St. Paul, Minnesota, specializes in laboratory testing and diagnostic services, with particular expertise in drug screening and clinical testing solutions for federal health agencies. Medtox has an established track record providing drug screening supplies, testing kits, and laboratory services to multiple federal agencies, most notably the Indian Health Service across facilities in South Dakota, Oklahoma, and New Mexico, as well as the Veterans Integrated Service Network. The urine drug testing analyzer and associated consumables support the Defense Health Agency's substance abuse screening and healthcare diagnostics programs across the military health system. This delivery order represents the company's continued role as a critical supplier of medical testing resources and laboratory equipment to federal government health services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 8/28/25 |